Come up with a name for your new list and we'll add to it:
Exonics Therapeutics raised a round of funding on November 09, 2017. Investors include
The Column Group.
Exonics Therapeutics is a biotechnology company focusing on utilizing gene editing technologies like CRISPR/Cas9 to advance the development of a treatment for Duchenne muscular dystrophy. Exonics' CRI…